organophosphonates has been researched along with Cachexia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, CB; Hamnvik, OP; Levy, BD; Loscalzo, J | 1 |
| Andrei, G; De Schutter, T; Duraffour, S; Matthys, P; Mitera, T; Naesens, L; Snoeck, R; Topalis, D; van den Oord, J | 1 |
3 other study(ies) available for organophosphonates and Cachexia
| Article | Year |
|---|---|
Clinical problem-solving. Wasting away.
Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Female; Hepatitis B; Humans; Hypophosphatemia; Liver Function Tests; Organophosphonates; Pelvic Bones; Phosphates; Radiography; Reverse Transcriptase Inhibitors; Tenofovir | 2014 |
Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Agents; Brain; Cachexia; Carcinoma; Cell Line, Tumor; Cidofovir; Cytokines; Cytosine; Female; Human papillomavirus 16; Humans; Kynurenine; Leukocyte Count; Liver; Mice; Mice, Nude; Organophosphonates; Papillomavirus Infections; Spleen; Splenomegaly; Tryptophan; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2013 |
Advances, challenges and growing frustration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cachexia; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Costs; Drug Therapy, Combination; Growth Hormone; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Immunity, Cellular; Infectious Disease Transmission, Vertical; Organophosphonates; Organophosphorus Compounds; Politics; Reverse Transcriptase Inhibitors; Zidovudine | 1995 |